Media Contact:
Ihor Andruch
CPRi Communications
201-641-1911 x50
iandruch@cpronline.com
FOR IMMEDIATE RELEASE
RISKS OF BREAST CANCER AND HEART DISEASE PROMPTS MILLIONS
OF WOMEN TO SEEK NATURAL ALTERNATIVES TO LOWER BAD CHOLESTEROL, INCREASE
GOOD CHOLESTEROL
Tea Extract to Lower LDL-C by 16.4 Percent with
No Adverse Effects.
Nashville, Tenn. - October 7, 2004 -The 2004 update from
the American Heart Association’s (AHA) Heart Disease and
Stroke Statistics documents that over 50 million American women
have borderline to high cholesterol levels, coupled with a recently
published study in the Journal of the National Cancer Institute
(2004: 96:1152-1160) that linked low levels of HDL or “good
cholesterol” with increased risks for developing postmenopausal
breast cancer, has prompted women across the country to identify
natural alternatives to lower “bad” cholesterol, increase “good” cholesterol
and reduce the risks of developing heart disease and breast cancer.
“The availability of Teaflavin®,
a non-prescription green tea extract with clinical trial evidence
that documents a 16% decrease in LDL, ‘bad cholesterol,’ and
a 3%-4% rise in HDL, ‘good cholesterol’ is well timed,” says
Jim Zhao, Ph.D. a molecular biologist and Chief Science Officer,
Nashai Biotech, LLC. “An estimated 280,000 women die annually
of either heart disease or breast cancer. We have responded to this
situation by developing an all natural product that has clinically
proven, positive effects for woman at an increased risk of developing
heart disease, breast cancer or both.”
The AHA has clearly stated the relationship between high cholesterol
and increased risks of heart disease. To mitigate these risks, an
increasing number of women have begun to incorporate more exercise,
a healthier diet and the addition of Teaflavin® to
their daily routine.
“Teaflavin® was designed
to offer women and men a non-prescription, heart-healthy alternative
to lowering their cholesterol without the potential adverse effects
of prescription medication,” says Dr. Zhao. “Teaflavin® offers
women a caffeine-free alternative for those seeking to reduce their
cholesterol that does not contribute to the muscle-wasting and liver
damage associated with the use of some prescription medications.”
The AHA recently announced new cholesterol guidelines that increase
the number of Americans classified with having cholesterol levels
that put them at “moderate to high risk” by several million.
A large number of Americans are already feeling the pinch of higher
prescription drug prices and this new “at risk population” may
not want to add additional prescriptions to those they may already
be taking. Many see Teaflavin® as
the natural solution.
For ordering information, please visit www.teaflavin.com or
call 800-876-4332.
About Nashai Biotech, LLC
Headquartered in Nashville, Tennessee with offices in Irvine, California
and Shanghai, China, Nashai Biotech, LLC (www.nashai.com)
produces patented, new generation formulas and ingredients based upon compelling
scientific evidence. Nashai's flagship product is Teaflavin®. |